Scopia Capital Management 13F holdings, Q4 2018
Holdings as of December 31, 2018 · filings on SEC EDGAR · latest filing →
Scopia Capital Management disclosed 28 US equity positions worth $2.9bn in its Q4 2018 13F filing. The largest position was S9Q at 11.4% of the reported book, followed by VST and ITRI. Against the Q3 2018 filing, it opened 4 new positions, added to 6 and reduced 13 among the top 28 holdings.
What did Scopia Capital Management own in Q4 2018? Top 28 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2018 |
|---|---|---|---|---|---|---|---|
| 1 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 11.4% | $334.9m | 4,645,750 | -13% | reduced | |
| 2 | VST VISTRA ENERGY CORP | Utilities | 10.4% | $306.1m | 13,373,518 | 11% | added |
| 3 | ITRI ITRON INC | Technology | 8.2% | $240.5m | 5,086,532 | -6% | reduced |
| 4 | JCI JOHNSON CTLS INTL PLC | Industrials | 8.1% | $238.2m | 8,034,412 | 7% | added |
| 5 | HORIZON PHARMA PLC | 7.1% | $209.6m | 10,725,642 | -27% | reduced | |
| 6 | JD JD COM INC | Consumer Cyclical | 5.4% | $160.1m | 7,651,273 | 7% | added |
| 7 | EQUITRANS MIDSTREAM CORPORAT | 4.8% | $141.9m | 7,086,893 | – | new | |
| 8 | RETROPHIN INC | 4.5% | $133.8m | 5,910,853 | -9% | reduced | |
| 9 | GWPH GW PHARMACEUTICALS PLC | 4.4% | $131.0m | 1,345,198 | -10% | reduced | |
| 10 | NXPI NXP SEMICONDUCTORS N V | Technology | 4.4% | $129.0m | 1,760,765 | – | new |
| 11 | QRVO QORVO INC | Technology | 4.4% | $128.3m | 2,112,943 | – | new |
| 12 | INVESTORS BANCORP INC NEW | 3.8% | $112.7m | 10,833,824 | -24% | reduced | |
| 13 | W WAYFAIR INC | Consumer Cyclical | 3.7% | $109.8m | 1,219,464 | 37% | added |
| 14 | ZOGENIX INC | 3.7% | $108.9m | 2,985,834 | -44% | reduced | |
| 15 | ACORDA THERAPEUTICS INC | 2.9% | $85.5m | 5,491,035 | -23% | reduced | |
| 16 | SPIRIT RLTY CAP INC NEW | 2.3% | $69.0m | 1,956,456 | – | new | |
| 17 | CNMD CONMED CORP | Healthcare | 2.1% | $62.2m | 969,160 | -20% | reduced |
| 18 | PTCT PTC THERAPEUTICS INC | Healthcare | 1.9% | $55.8m | 1,626,965 | 1% | added |
| 19 | PROTHENA CORP PLC | 1.6% | $47.6m | 4,618,164 | 18% | added | |
| 20 | ENTERCOM COMMUNICATIONS CORP | 1.1% | $33.6m | 5,888,683 | -26% | reduced | |
| 21 | Y MABS THERAPEUTICS INC | 1.1% | $31.3m | 1,587,566 | 0% | held | |
| 22 | LA JOLLA PHARMACEUTICAL CO | 0.8% | $22.5m | 2,387,336 | -8% | reduced | |
| 23 | AYI ACUITY BRANDS INC | Industrials | 0.7% | $21.4m | 185,930 | 0% | held |
| 24 | THC TENET HEALTHCARE CORP | Healthcare | 0.5% | $14.9m | 870,695 | -53% | reduced |
| 25 | INTERCEPT PHARMACEUTICALS IN | 0.2% | $6.5m | 64,961 | 0% | held | |
| 26 | FOSL FOSSIL GROUP INC | Consumer Cyclical | 0.2% | $6.2m | 395,925 | 0% | held |
| 27 | SPIRIT MTA REIT | 0.1% | $4.2m | 587,940 | -76% | reduced | |
| 28 | MNKD MANNKIND CORP | Healthcare | 0.1% | $1.8m | 1,666,498 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.